We’ll Soon Have Tools To Protect Infants Against RSV. Can We Put Them To Good Use?

Sarah Long, MD, a professor in the College of Medicine, was quoted in a May 24 STAT article about vaccines and monoclonal antibody products for RSV that are racing toward the end of the development pipeline.

View More